No increased rate of SARS-CoV-2 infection for patients with inflammatory rheumatic diseases compared with the general population in the city of Hamburg (Germany)

Affiliations

¹ Rheumatologie und klinische Immunolgie, Rheumatologie im Struenseehaus, Hamburg, Germany.
² Nephrology and Rheumatology, Department of Medicine III, University of Hamburg Faculty of Medicine, Hamburg, Germany c.iking-konert@uke.de.

Comment

Peer Aries et al. Ann Rheum Dis. 2022 Dec.

. 2022 Dec;81(12):e245.

doi: 10.1136/annrheumdis-2020-218400. Epub 2020 Aug 7.

¹ Rheumatologie und klinische Immunolgie, Rheumatologie im Struenseehaus, Hamburg, Germany.
² Nephrology and Rheumatology, Department of Medicine III, University of Hamburg Faculty of Medicine, Hamburg, Germany c.iking-konert@uke.de.

No abstract available

Keywords: autoimmune diseases; epidemiology; immune system diseases.

Conflict of interest statement

Competing interests: None declared.

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC; COVID-19 Global Rheumatology Alliance. Gianfrancesco M, et al. Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871. Epub 2020 May 29. Ann Rheum Dis. 2020. PMID: 32471903 Free PMC article.